US regulatory chief’s resignation raises alarms in biotech industry

The resignation of Peter Marks, long-time director of the US Food and Drug Administration’s (FDA) centre responsible for assessing vaccines and other biological products, has exacerbated growing concerns within the US biotechnology industry and beyond.